共 50 条
- [21] A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular CarcinomaTECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21Teng, Ying论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R China Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R ChinaDing, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R China Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R ChinaLi, Wendong论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R China Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R ChinaSun, Wei论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R China Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R ChinaChen, Jinglong论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R China Capital Med Univ, Beijing Ditan Hosipital, 8 Jingshun East St, Beijing 100102, Peoples R China
- [22] Immune checkpoint inhibitor plus tyrosine kinase inhibitor for unresectable hepatocellular carcinoma in the real worldANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)Xie, Diyang论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R ChinaSun, Qiman论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R ChinaWang, Xiaoying论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R ChinaZhou, Jian论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R ChinaFan, Jia论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R ChinaRen, Zhenggang论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R ChinaGao, Qiang论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China
- [23] Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysisFRONTIERS IN ONCOLOGY, 2022, 12Yang, Xue-Gang论文数: 0 引用数: 0 h-index: 0机构: Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China Sichuan Univ, Huaxi MR Res Ctr HMRRC, Functi & mol imaging Key Lab Sichuan Prov, Dept Radiol,West China Hosp, Chengdu, Peoples R China Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaSun, Yan-Yuan论文数: 0 引用数: 0 h-index: 0机构: Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaWang, Hai-Qing论文数: 0 引用数: 0 h-index: 0机构: Sichuan Canc Ctr, Dept Hepatobiliary Pancreat Surg, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaLi, De-Shan论文数: 0 引用数: 0 h-index: 0机构: Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaXu, Guo-Hui论文数: 0 引用数: 0 h-index: 0机构: Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaHuang, Xiao-Qi论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, Huaxi MR Res Ctr HMRRC, Functi & mol imaging Key Lab Sichuan Prov, Dept Radiol,West China Hosp, Chengdu, Peoples R China Sichuan Canc Ctr, Dept Intervent Radiol, Sichuan Canc Hosp & Inst, Chengdu, Peoples R China
- [24] Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching studyFRONTIERS IN ONCOLOGY, 2022, 12Zhu, Di论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaMa, Kun论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ Chinese Med, Dept Intervent Radiol, Affiliated Hosp, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaYang, Wei论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaZhou, Hai-Feng论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaShi, Qi论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaRen, Jian-Wu论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaXie, Yu-Guan论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaLiu, Sheng论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaShi, Hai-Bin论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R ChinaZhou, Wei-Zhong论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Peoples R China
- [25] Prognostic value of platelet-to-lymphocyte ratio in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization and tyrosine kinase inhibitors plus immune checkpoints inhibitorsFRONTIERS IN ONCOLOGY, 2024, 14Guo, Yiwan论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R ChinaWu, Wenlong论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Intervent Radiol, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R ChinaSun, Bo论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Intervent Radiol, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R ChinaGuo, Tingting论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R ChinaSi, Keke论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R ChinaZheng, Chuansheng论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R ChinaLi, Xin论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China
- [26] Efficacy and Safety Analysis of Transarterial Chemoembolization Plus Donafenib With or Without Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical StudyJOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1207 - 1219Li, Jinpeng论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Radiat Oncol,K, Tianjin 300060, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Intervent Therapy 1, Jinan 250117, Shandong, Peoples R China Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Radiat Oncol,K, Tianjin 300060, Peoples R ChinaLi, Yan论文数: 0 引用数: 0 h-index: 0机构: Shanghe Cty Peoples Hosp, Dept Radiol, Jinan 250000, Peoples R China Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Radiat Oncol,K, Tianjin 300060, Peoples R ChinaSong, Jinlong论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Intervent Therapy 1, Jinan 250117, Shandong, Peoples R China Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Radiat Oncol,K, Tianjin 300060, Peoples R ChinaZhao, Lujun论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Radiat Oncol,K, Tianjin 300060, Peoples R China Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Radiat Oncol,K, Tianjin 300060, Peoples R China
- [27] Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective studyFRONTIERS IN ONCOLOGY, 2025, 15Bu, Junfeng论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R ChinaLi, Zihan论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Med Sch, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R ChinaHu, Die论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R ChinaLan, Ling论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R ChinaHuang, Jiwei论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R ChinaWang, Xin论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Radiat Oncol, Chengdu 610041, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R ChinaLi, Qiu论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Med Oncol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R ChinaZhou, Jin论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R ChinaZeng, Yong论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China
- [28] Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world studyBMC GASTROENTEROLOGY, 2021, 21 (01)Han, Yue论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaCao, Guang论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Intervent Therapy, Beijing 100142, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaSun, Bin论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Youan Hosp, Ctr Intervent Oncol & Liver Dis, Beijing 100069, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaWang, Jian论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, First Hosp, Dept Intervent Radiol & Vasc Surg, Beijing 100034, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaYan, Dong论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaXu, Haifeng论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Intervent Therapy, Beijing 100142, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaShi, Qinsheng论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Youan Hosp, Ctr Intervent Oncol & Liver Dis, Beijing 100069, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLiu, Zechuan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, First Hosp, Dept Intervent Radiol & Vasc Surg, Beijing 100034, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaZhi, Weihua论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaXu, Liang论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Intervent Therapy, Beijing 100142, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLiu, Bojun论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Beijing Youan Hosp, Ctr Intervent Oncol & Liver Dis, Beijing 100069, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaZou, Yinghua论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, First Hosp, Dept Intervent Radiol & Vasc Surg, Beijing 100034, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China
- [29] Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world studyBMC Gastroenterology, 21Yue Han论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalGuang Cao论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalBin Sun论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalJian Wang论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalDong Yan论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalHaifeng Xu论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalQinsheng Shi论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalZechuan Liu论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalWeihua Zhi论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalLiang Xu论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalBojun Liu论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalYinghua Zou论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital
- [30] Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World StudyJOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1993 - 2003Shen, Xiao论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R ChinaZhang, Jin-Xing论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R ChinaLiu, Jin论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Dept Clin Med Res Inst, Nanjing 210029, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R ChinaLiu, Sheng论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R ChinaShi, Hai-Bin论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R ChinaCheng, Yuan论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Jinling Hosp, Affiliated Hosp, Dept Med Oncol,Med Sch, Nanjing 210002, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R ChinaZhang, Qing-Qiao论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Intervent Radiol & Vasc Surg, Xuzhou 221006, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R ChinaYin, Guo-Wen论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Canc Hosp, Dept Intervent Radiol, Nanjing 210009, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R ChinaZu, Qing-Quan论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China